Skip to main content

Elona Kogan

Equibles does not estimate personal net worth.

Get an email with a short summary when Seer, Inc. publishes a filing, an earnings call transcript or a press release.

Get SEER alerts

About Elona Kogan

Elona Kogan is recorded as General Counsel at Seer, Inc. (SEER) since November 17, 2023. Earlier roles on record: General Counsel at Cartesian Therapeutics, Inc. (RNAC) until August 18, 2020. Seer, Inc. reported in an 8-K filed July 19, 2024 that Elona Kogan resigned as Chief Legal Officer and Corporate Secretary, effective July 26, 2024. Seer, Inc. reported in an 8-K filed November 17, 2023 that Elona Kogan was appointed Chief Legal Officer, effective November 17, 2023. The proxy statement of Seer, Inc. reports total compensation of $809,295 for Elona Kogan in fiscal 2024, including a base salary of $286,115. Disclosed compensation is on record for 6 fiscal years. Seer, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Seer, Inc. includes Omid Farokhzad (CEO and Board Member), Charles Endweiss (CFO and Chief Accounting Officer), David Hallal (Board Member) and 7 others.

“On July 16, 2024, Elona Kogan resigned as the Chief Legal Officer and Corporate Secretary of Seer, Inc. (the "Company"), to pursue other career opportunities. Her resignation, which is effective July 26, 2024, is not related to any disagreement with the Company, including on any matter relating to the Company's operations, policies or practices.”
Seer, Inc. Form 8-K, filed July 19, 2024 · Read the filing
“Also on November 17, 2023, the Board appointed Elona Kogan to the office of Chief Legal Officer of the Company.”
Seer, Inc. Form 8-K, filed November 17, 2023 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

General Counsel

2023-11-17–present

Leadership on record at Seer, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Seer, Inc. (SEER) $286,115 $809,295
2023 Seer, Inc. (SEER) $416,487 $1,364,617
2022 Seer, Inc. (SEER) $394,584 $2,880,289
2021 Seer, Inc. (SEER) $375,000 $525,000
2020 Seer, Inc. (SEER) $8,320 $3,810,636
2019 Cartesian Therapeutics, Inc. (RNAC) $296,692 $1,359,486

Recent activity